David Foster

5.3k citations

109 papers · 4.0k indexed · 1 hit paper · h-index 31

Impact in

Anesthesiology and Pain Medicine top 0.5%
- Pain Management and Opioid Use
Neurology top 1%
- Neurological diseases and metabolism

Papers in

Anesthesiology and Pain Medicine 19
- Pain Management and Opioid Use 15
Pharmacology 12
- Pharmacogenetics and Drug Metabolism 10

Co-authors: Richard N. Upton Ahmad Y. Abuhelwa Andrew A. Somogyi Felix Bochner S. J. DeArmond Marilyn Torchia Shuyan Yang Jason M. White
Journals: British Journal of Clinical Pharmacology (13 papers)Basic & Clinical Pharmacology & Toxicology (6 papers)The AAPS Journal (4 papers)Journal of Pharmacokinetics and Pharmacodynamics (4 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (3 papers)
Partner nations: Australia United States Denmark

In The Last Decade

David Foster

107 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. 1993 · 373 citations

Peers

Countries citing papers authored by David Foster

Since Specialization

Citations

This map shows the geographic impact of David Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Foster more than expected).

Fields of papers citing papers by David Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Foster. The network helps show where David Foster may publish in the future.

Co-authors

The 25 scholars most cited alongside David Foster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Foster Line = papers co-authored together David Foster links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetic‐pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis British Journal of Clinical Pharmacology ·Jiun Ming Tan, Richard N. Upton, David Foster, Susanna Proudman, Varun Dhir, Michael D. Wiese	2024	0
2	Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression Clinical Pharmacology & Therapeutics ·Ahmad Y. Abuhelwa, Andrew A. Somogyi, Colleen Loo, Paul Glue, Daniel T. Barratt, David Foster	2022	7
3	Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis Therapeutic Advances in Musculoskeletal Disease ·Ahmad Y. Abuhelwa, David Foster, Arkady T. Manning‐Bennett, Michael J. Sorich, Susanna Proudman, Michael D. Wiese, Ashley M. Hopkins	2021	1
4	Effect of Roux‐en‐Y gastric bypass on the pharmacokinetic‐pharmacodynamic relationships of liquid and controlled‐release formulations of oxycodone Basic & Clinical Pharmacology & Toxicology ·Louise Ladebo, Ahmad Y. Abuhelwa, David Foster, Jens Peter Kroustrup, Grzegorz J. Pacyk, Kenneth T. Kongstad, Asbjørn Mohr Drewes, Lona Louring Christrup, Anne Estrup Olesen	2021	5
5	Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs Scientific Reports ·Ahmad Y. Abuhelwa, Ashley M. Hopkins, Michael J. Sorich, Susanna Proudman, David Foster, Michael D. Wiese	2020	21
6	Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice Cancer Chemotherapy and Pharmacology ·Jim H. Hughes, Richard N. Upton, Stephanie E. Reuter, Darlene M. Rozewski, Mitch A. Phelps, David Foster	2019	8
7	Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers European Journal of Drug Metabolism and Pharmacokinetics ·Ahmad Y. Abuhelwa, Stuart Mudge, Richard N. Upton, David Foster	2018	9
8	Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data Antimicrobial Agents and Chemotherapy ·Ashley M. Hopkins, Jessica Wojciechowski, Ahmad Y. Abuhelwa, Stuart Mudge, Richard N. Upton, David Foster	2017	9
9	Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies The AAPS Journal ·Jessica Wojciechowski, Richard N. Upton, Diane R. Mould, Michael D. Wiese, David Foster	2017	27
10	Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats PLoS ONE ·Jana Leshinsky, Andrew J. McLachlan, David Foster, Ross Norris, Vanessa R. Barrs	2017	6
11	Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug Pharmaceutical Research ·Ahmad Y. Abuhelwa, Stuart Mudge, David Hayes, Richard N. Upton, David Foster	2016	29
12	Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted States Antimicrobial Agents and Chemotherapy ·Ahmad Y. Abuhelwa, David Foster, Stuart Mudge, David Hayes, Richard N. Upton	2015	90
13	Modelling concentration–analgesia relationships for morphine to evaluate experimental pain models European Journal of Pharmaceutical Sciences ·Eva Sverrisdóttir, David Foster, Richard N. Upton, Anne Estrup Olesen, Trine Meldgaard Lund, Charlotte Gabel‐Jensen, Asbjørn Mohr Drewes, Lona Louring Christrup, Mads Kreilgaard	2014	17
14	Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model Journal of Materials Science Materials in Medicine ·Andrew L. Lewis, R. Holden, Shui T. Chung, Peter Czuczman, Timothy R. Kuchel, John Finnie, Susan Judith Porter, David Foster	2012	16
15	Stereoselective Quantification of Methadone and a d6-labeled Isotopomer Using High Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization Mass-Spectrometry: Application to a Pharmacokinetic Study in a Methadone Maintained Subject Therapeutic Drug Monitoring ·David Foster, Erin Morton, Georg Heinkele, Thomas E. M rdter, Andrew A. Somogyi	2006	13
16	Blood–brain distribution of morphine‐6‐glucuronide in sheep British Journal of Pharmacology ·Hanne H. Villesen, David Foster, Richard N. Upton, Lona Louring Christrup, Andrew A. Somogyi, A. Martinez, C. M. Grant	2006	2
17	Retinoic acid induces nonuniform alveolar septal growth after right pneumonectomy Journal of Applied Physiology ·Xiao Yan, Dennis J. Bellotto, David Foster, Robert L. Johnson, Herbert K. Hagler, Aaron S. Estrera, Connie C. W. Hsia	2004	30
18	Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre British Journal of Clinical Pharmacology ·Jaroon Jittiwutikarn, Robert Ali, Jason M. White, Felix Bochner, Andrew A. Somogyi, David Foster	2004	16
19	Stereoselective quantification of methadone and its major oxidative metabolite, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, in human urine using high-performance liquid chromatography Journal of Chromatography B Biomedical Sciences and Applications ·David Foster, Andrew A. Somogyi, Felix Bochner	2000	30
20	Resistance of Arachis hypogaea L. and wild relatives to Cercospora arachidicola Hori. Oleagineux ·David Foster, H. T. Stalker, J. C. Wynne, M. K. Beute	1981	16

About David Foster

David Foster is a scholar working on Anesthesiology and Pain Medicine, Pharmacology, Small Animals, Pharmacology and Pharmaceutical Science, having authored 109 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pain Management and Opioid Use (15 papers), Drug Transport and Resistance Mechanisms (11 papers), Pain Mechanisms and Treatments (10 papers), Pharmacogenetics and Drug Metabolism (10 papers), Opioid Use Disorder Treatment (10 papers), Anesthesia and Pain Management (9 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Veterinary Pharmacology and Anesthesia (7 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (507 citations), Neurology (527 citations), Pharmacology (438 citations), Toxicology (120 citations) and Pharmaceutical Science (213 citations). David Foster has collaborated with scholars based in Australia, United States and Denmark. Frequent co-authors include Richard N. Upton, Ahmad Y. Abuhelwa, Andrew A. Somogyi, Felix Bochner, S. J. DeArmond, Marilyn Torchia, Shuyan Yang, Jason M. White, Lona Louring Christrup and Stanley B. Prusiner. Their work appears in journals such as British Journal of Clinical Pharmacology, Basic & Clinical Pharmacology & Toxicology, The AAPS Journal, Journal of Pharmacokinetics and Pharmacodynamics and American Journal of Physiology-Lung Cellular and Molecular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact